Would not due diligence involve risk analysis of the FDA trial? A deal once the FDA trial is successful would be less risky for them....may be mor expensive but less risk. May be why MED3000 hasn't hit the shelves in EU/UK yet. I would like some explanation from analyst question time. unlikely to get any!
Could it be that the distributor partner(s) for the EU/UK are waiting for the results from the FDA trial before commiting to a big marketing push? I could see the logic from their POV. Personally I want to see MED3000 on the shelf ASAP.
It's been about a year since CE mark was obtained. Any sign that it will be available to buy in UK or elsewhere? Would be nice to see it advertised and available on the shelf or online. Would be a big milestone for the company.